-
Something wrong with this record ?
Hornhautvernetzung beim Keratokonus: "Epi-off" oder "Epi-on" [Cross-Linking in Keratoconus: "Epi-off" or "Epi-on"?]
F. Raiskup, V. Veliká, M. Veselá, E. Spörl,
Language German Country Germany
Document type English Abstract, Journal Article, Review
- MeSH
- Photochemotherapy methods MeSH
- Photosensitizing Agents administration & dosage MeSH
- Keratoconus pathology therapy MeSH
- Combined Modality Therapy methods MeSH
- Humans MeSH
- Evidence-Based Medicine MeSH
- Cross-Linking Reagents administration & dosage MeSH
- Riboflavin administration & dosage MeSH
- Epithelium, Corneal surgery MeSH
- Ultraviolet Therapy methods MeSH
- Treatment Outcome MeSH
- Check Tag
- Humans MeSH
- Publication type
- English Abstract MeSH
- Journal Article MeSH
- Review MeSH
Corneal cross-linking can halt the progression of keratoconus, but what is the best approach for treatment? There are a number of treatment options for keratoconus, but only corneal cross-linking (CXL) appears to halt the progression of the disease. To guarantee effective cross-linking, CXL treatment involves removal of the corneal epithelium prior to riboflavin application and ultraviolet light illumination - "epi-off" CXL. Several methods of "epi-on" (transepithelial) CXL have been proposed, such as keeping the corneal epithelium intact which should be less painful and help avoid other CXL-associated adverse events. The evidence so far is that epi-off CXL remains the most effective method of strengthening the cornea and slowing keratoconus progression - but transepithelial methods are gaining ground.
Klinik für Augenheilkunde Universitätsklinikum Carl Gustav Carus Dresden
Klinik für Augenheilkunde Universitätsklinikum Hradec Králové Tschechische Republik
Cross-Linking in Keratoconus: "Epi-off" or "Epi-on"?
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc16027831
- 003
- CZ-PrNML
- 005
- 20181008112805.0
- 007
- ta
- 008
- 161005s2015 gw f 000 0|ger||
- 009
- AR
- 024 7_
- $a 10.1055/s-0035-1546155 $2 doi
- 024 7_
- $a 10.1055/s-0035-1546155 $2 doi
- 035 __
- $a (PubMed)26678902
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a ger
- 044 __
- $a gw
- 100 1_
- $a Raiskup, Frederik $7 xx0227886 $u Klinik für Augenheilkunde, Universitätsklinikum Carl Gustav Carus, Dresden.
- 245 10
- $a Hornhautvernetzung beim Keratokonus: "Epi-off" oder "Epi-on" / $c F. Raiskup, V. Veliká, M. Veselá, E. Spörl,
- 246 31
- $a [Cross-Linking in Keratoconus: "Epi-off" or "Epi-on"?].
- 520 9_
- $a Corneal cross-linking can halt the progression of keratoconus, but what is the best approach for treatment? There are a number of treatment options for keratoconus, but only corneal cross-linking (CXL) appears to halt the progression of the disease. To guarantee effective cross-linking, CXL treatment involves removal of the corneal epithelium prior to riboflavin application and ultraviolet light illumination - "epi-off" CXL. Several methods of "epi-on" (transepithelial) CXL have been proposed, such as keeping the corneal epithelium intact which should be less painful and help avoid other CXL-associated adverse events. The evidence so far is that epi-off CXL remains the most effective method of strengthening the cornea and slowing keratoconus progression - but transepithelial methods are gaining ground.
- 650 _2
- $a kombinovaná terapie $x metody $7 D003131
- 650 _2
- $a reagencia zkříženě vázaná $x aplikace a dávkování $7 D003432
- 650 _2
- $a rohovkový epitel $x chirurgie $7 D019573
- 650 _2
- $a medicína založená na důkazech $7 D019317
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a keratokonus $x patologie $x terapie $7 D007640
- 650 _2
- $a fotochemoterapie $x metody $7 D010778
- 650 _2
- $a fotosenzibilizující látky $x aplikace a dávkování $7 D017319
- 650 _2
- $a riboflavin $x aplikace a dávkování $7 D012256
- 650 _2
- $a výsledek terapie $7 D016896
- 650 _2
- $a terapie ultrafialovými paprsky $x metody $7 D014467
- 655 _2
- $a anglický abstrakt $7 D004740
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Veliká, V $u Klinik für Augenheilkunde, Universitätsklinikum, Hradec Králové, Tschechische Republik.
- 700 1_
- $a Veselá, M $u Klinik für Augenheilkunde, Universitätsklinikum, Hradec Králové, Tschechische Republik.
- 700 1_
- $a Spörl, E $u Klinik für Augenheilkunde, Universitätsklinikum Carl Gustav Carus, Dresden.
- 773 0_
- $w MED00003077 $t Klinische Monatsblätter für Augenheilkunde $x 1439-3999 $g Roč. 232, č. 12 (2015), s. 1392-6
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/26678902 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20161005 $b ABA008
- 991 __
- $a 20181008113251 $b ABA008
- 999 __
- $a ok $b bmc $g 1166145 $s 952461
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2015 $b 232 $c 12 $d 1392-6 $e 20151217 $i 1439-3999 $m Klinische Monatsblätter für Augenheilkunde $n Klin Monatsbl Augenheilkd $x MED00003077
- LZP __
- $a Pubmed-20161005
